This Strategic Dialogue will feature distinguished judges and finalists for the Horizon Prize pitch competition, powered by MIT Solve. Roughly 85% of biomedical research funding is wasted due to inefficiencies, highlighting the opportunity to decrease waste and redundancies while increasing the impact of research and development investments. For the 10% of people affected by rare disease – a population with notably inefficient and expensive diagnostic journeys – increased sustainability could shorten diagnostic timelines, decrease carbon emissions, and allow research funding to go further – resulting in more treatments for patients. This year, The Horizon Prize, powered by MIT Solve, seeks technology-based solutions that decrease the environmental impact of the rare disease health care space and alleviate burdens for rare disease families. This session will be the final pitch competition of the finalists who will compete to win the Horizon Prize. The winner will later be announced on the Metropolitan East Stage.

Horizon Therapeutics is a 2023 Concordia Annual Summit Patron Programming Sponsor.